Skip to Main Content

Author Details

David J Liewehr
Center for Cancer Research
1999
110
51
PMIDPaper TitleJournal TitlePublished Year
36322002The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.Clin Cancer Res2023
36322002The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.Clin Cancer Res2023
34898541Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma.Curr Oncol2021
34898541Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma.Curr Oncol2021
32152628Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions.Neuro Oncol2020
32152628Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions.Neuro Oncol2020
32943455Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform Neurofibromas.Clin Cancer Res2020
32943455Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform Neurofibromas.Clin Cancer Res2020
31077558Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.Cytometry B Clin Cytom2019
30817750Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer.PLoS One2019
31077558Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.Cytometry B Clin Cytom2019
31367538A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer.Transl Lung Cancer Res2019
31367538A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer.Transl Lung Cancer Res2019
30817750Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer.PLoS One2019
28792255Host-related immunodeficiency in the development of multiple myeloma.Leuk Lymphoma2018
28540748Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma.Leuk Lymphoma2018
28792255Host-related immunodeficiency in the development of multiple myeloma.Leuk Lymphoma2018
30053652Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma.Leuk Res2018
29718344Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1.Neuro Oncol2018
30053652Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma.Leuk Res2018
29718344Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1.Neuro Oncol2018
28540748Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma.Leuk Lymphoma2018
27762068Procalcitonin and cytokine profiles in engraftment syndrome in pediatric stem cell transplantation.Pediatr Blood Cancer2017
27762068Procalcitonin and cytokine profiles in engraftment syndrome in pediatric stem cell transplantation.Pediatr Blood Cancer2017
27245829Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.Clin Cancer Res2016
27245829Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.Clin Cancer Res2016
26453135Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors.Surgery2016
27883295Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer.Pharmacogenomics2016
27794397Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.Lung Cancer2016
27620882ANG1005 for breast cancer brain metastases: correlation between <sup>18</sup>F-FLT-PET after first cycle and MRI in response assessment.Breast Cancer Res Treat2016
26453135Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors.Surgery2016
27794397Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.Lung Cancer2016
27883295Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer.Pharmacogenomics2016
27620882ANG1005 for breast cancer brain metastases: correlation between <sup>18</sup>F-FLT-PET after first cycle and MRI in response assessment.Breast Cancer Res Treat2016
25690794Multiple regions of Kaposi's sarcoma-associated herpesvirus ORF59 RNA are required for its expression mediated by viral ORF57 and cellular RBM15.Viruses2015
25667274Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.J Clin Oncol2015
25690794Multiple regions of Kaposi's sarcoma-associated herpesvirus ORF59 RNA are required for its expression mediated by viral ORF57 and cellular RBM15.Viruses2015
25685318Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades.Hepat Oncol2015
25891346Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data.Br J Haematol2015
25891346Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data.Br J Haematol2015
25685318Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades.Hepat Oncol2015
25667274Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.J Clin Oncol2015
24462038Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases.Leuk Res2014
24462038Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases.Leuk Res2014
24775564Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.Mol Cancer2014
24634373Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.Clin Cancer Res2014
24565030The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors.J Transl Med2014
24514956A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.Cancer Immunol Immunother2014
25073973Role of nucleotide excision repair and p53 in zidovudine (AZT)-induced centrosomal deregulation.Environ Mol Mutagen2014
24778277Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer.Cancer Immunol Res2014
  • 1 - 50 of 220

Recommended Authors

Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 1
University of California
Career Start Year 2003
Number of shared co-authors 0
University of Virginia
Career Start Year 2002
Number of shared co-authors 1
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 2
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 1
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 0
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 0
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1989
Number of shared co-authors 1
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 1
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 2
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 0
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
Queen's University
Career Start Year 1982
Number of shared co-authors 6
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 1
College of Agriculture and Life Sciences, Cornell University
Career Start Year 1977
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 82
Center for Cancer Research, National Cancer Institute
Co-authored papers 12
Center for Cancer Research
Co-authored papers 12
National Cancer Institute, National Institutes of Health
Co-authored papers 9
Co-authored papers 8
National Cancer Institute
Co-authored papers 5
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Co-authored papers 5
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Meyer Cancer Center
Co-authored papers 5
National Institutes of Health, National Cancer Institute, Center for Cancer Research
Co-authored papers 4
Co-authored papers 4
Center for Cancer Research
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
National Cancer Institute
Co-authored papers 4
University of Colorado School of Medicine
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Frederick National Laboratory for Cancer Research
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Center for Cancer Research
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Program Resources Inc. NCI-FCDRC
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Center for Cancer Training, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2